Related Experiment Video
Updated: Jun 23, 2026
06:26
Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
Preconditioning with diazoxide prevents reoxygenation-induced rigor-type hypercontracture
1Institute of Physiology, Justus-Liebig-University Giessen, Germany.
Journal of Molecular and Cellular Cardiology
|May 2, 2009
Summary
Pharmacological preconditioning with diazoxide protects heart cells from reperfusion injury by improving mitochondrial function and energy recovery, preventing excessive cell shortening during reoxygenation.
Area of Science:
- Cardiology
- Cellular Physiology
- Mitochondrial Biology
Background:
- Ischemic preconditioning offers protection against reperfusion injury in the post-ischemic myocardium.
- Cardiomyocyte hypercontracture, a key reperfusion injury mechanism, involves Ca(2+)-independent rigor contracture.
- Rigor contracture's severity depends on metabolic recovery speed during reoxygenation.
Purpose of the Study:
- To investigate if preconditioning cardiomyocyte mitochondria improves mitochondrial function.
- To determine if improved mitochondrial function restores energy balance during reoxygenation.
- To test if this prevents rigor contracture and subsequent hypercontracture.
Main Methods:
- Adult rat cardiomyocytes subjected to anoxia/reoxygenation.
- Preconditioning with diazoxide (mitochondrial ATP-sensitive K(+) channel opener).
- Assessment of cardiomyocyte hypercontracture, rigor contracture, and phosphocreatine resynthesis.
Main Results:
- Diazoxide preconditioning significantly reduced reoxygenation-induced hypercontracture.
- This reduction was linked to attenuated Ca(2+)-independent rigor contracture.
- Diazoxide accelerated phosphocreatine resynthesis and improved cardiac function in isolated hearts.
Conclusions:
- Pharmacological preconditioning with diazoxide protects cardiomyocytes against rigor hypercontracture.
- This protection is mediated by enhanced mitochondrial function and improved energy recovery during early reoxygenation.
- Diazoxide's effects are dependent on mitochondrial ATP-sensitive K(+) channel activity and mitochondrial function.
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:25Hyperpnea and Hyperventilation
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...